You Save:
Inclusive of all taxes
Product not available
Semaglutide injection (Ozempic) is used along with a diet and exercise program to control blood sugar levels in adults with type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood) when other medications did not control the sugar levels well enough. Semaglutide injection (Ozempic) is also used to reduce the risk of a stroke, heart attack, or death in adults who have type 2 diabetes along with heart and blood vessel disease. It is not used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood) or diabetic ketoacidosis (a serious condition that may develop if high blood sugar is not treated). Semaglutide injection is not used instead of insulin to treat people with diabetes who need insulin. Semaglutide injection (Wegovy) is used along with an individualized low-calorie, low-fat diet and exercise program to help with weight loss in obese adults or overweight adults who may also have high blood pressure, diabetes, or high cholesterol. Semaglutide injection (Wegovy) is also used along with an individualized low-calorie, low-fat diet and exercise program to help with weight loss in obese children 12 years of age or older. Semaglutide injection is in a class of medications called incretin mimetics. It works by helping the pancreas to release the right amount of insulin when blood sugar levels are high. Insulin helps move sugar from the blood into other body tissues where it is used for energy. Semaglutide injection also works by slowing the movement of food through the stomach and may decrease appetite and cause weight loss.
Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Using medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.
How should this medicine be used?
Semaglutide injection comes as a solution (liquid) in a prefilled dosing pen to inject subcutaneously (under the skin). It is usually injected once a week without regard to meals. Use semaglutide injection on the same day each week at any time of day. You may change the day of the week that you use semaglutide as long as it has been 2 or more days (48 or more hours) since you used your last dose. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use semaglutide injection exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.
Your doctor will probably start you on a low dose of semaglutide injection and increase your dose after 4 weeks. Your doctor may increase your dose again after another 4 weeks based on your body's response to the medication.
Semaglutide injection helps to control diabetes and weight loss, but it is not a cure. Continue to use semaglutide injection even if you feel well. Do not stop using semaglutide injection without talking to your doctor.
Carefully read the manufacturer's instructions for use that comes with the medication. These instructions describe how to inject a dose of semaglutide injection. Be sure to ask your pharmacist or doctor if you have any questions about how to inject this medication.
Always look at the semaglutide solution before you inject it. It should be clear, colorless, and free of particles. Do not use semaglutide if it is colored, cloudy, thickened, or contains solid particles, or if the expiration date on the bottle has passed.
Never reuse needles and never share needles or pens. Always remove the needle right after you inject your dose. Dispose of needles in a puncture-resistant container. Ask your doctor or pharmacist how to dispose of the puncture resistant container.
You can inject semaglutide in your upper arm, thigh, or stomach area. Change (rotate) the injection site with each injection. You can inject semaglutide and insulin in the same body area, but you should not give the injections right next to each other. Allow the pen to warm to room temperature before injecting if the pen was stored in the refrigerator.
Country Of Origin : India
Fitaro 1mg injection is a potent semaglutide-based therapy used to manage type 2 diabetes and aid weight loss. This medication serves as an essential component of a comprehensive treatment program, including diet and exercise. It is designed to help patients control blood sugar levels and reduce cardiovascular risks such as stroke and heart attack. Moreover, it supports weight loss in obese adults and children 12 years and older by working synergistically with a tailored dietary and physical activity plan.
Fitaro 1mg injection, containing semaglutide, is integral for adults with type 2 diabetes who struggle with optimal blood sugar control despite other treatments. It aids in lowering and stabilizing blood sugar levels by:
Enhancing Insulin Secretion: Semaglutide mimics the activity of incretin hormones, which stimulate the pancreas to release insulin when blood sugar levels are elevated.
Reducing Glucose Production: It helps reduce the liver's glucose production, leading to better glycemic control.
Delaying Gastric Emptying: This slows the movement of food through the stomach, promoting a feeling of fullness and potentially aiding weight loss.
Beta-Cell Function: It helps preserve beta-cell function, essential for continuous insulin production.
Patients using this medication may see a significant reduction in hemoglobin A1c levels, an indicator of blood sugar control over time.
In addition to managing blood sugar, Fitaro 1mg injection plays a crucial role in diminishing the risks associated with cardiovascular diseases. Patients with type 2 diabetes often face heightened risks of heart attack, stroke, and cardiovascular death. Clinical studies have indicated that semaglutide reduces these risks, making it a vital component of managing not just diabetes but its associated complications.
Fitaro 1mg injection, under the brand name Wegovy, is also employed for weight management:
Weight Loss Aid: When combined with an individualized low-calorie, low-fat diet and exercise regimen, semaglutide effectively helps obese adults and overweight adults with comorbid conditions like hypertension or hypercholesterolemia lose weight.
Appetite Suppression: It decreases appetite, making it easier to adhere to dietary restrictions.
Usage in Adolescents: It extends its benefits to obese children aged 12 and older, providing a comprehensive approach to tackling obesity from a young age.
Fitaro 1mg injection is administered once weekly, subcutaneously, without regard to meals. Critical steps to follow for proper administration include:
Consistency: Use it on the same day each week. If a schedule change is necessary, ensure at least 48 hours have elapsed since the last dose.
Dose Adjustment: Initiate treatment with a lower dose, following medical advice. Adjust the dose every four weeks based on response and tolerance.
Injection Sites: Inject into the upper arm, thigh, or abdominal area, rotating the site with each administration to minimize localized reactions.
Drug Inspection: Confirm the solution is clear, colorless, and free from particles before each injection. Avoid use if the solution appears discolored, cloudy, or contains solid particles.
Needle Care: Never reuse or share needles or pens, and always remove and dispose of needles in a puncture-resistant container immediately after use.
Temperature: Ensure the pen has reached room temperature if it was stored in the refrigerator.
Semaglutide is an analog of human glucagon-like peptide-1 (GLP-1), a member of the incretin family. It exerts its effects through multiple mechanisms:
GLP-1 Receptor Agonist: Semaglutide primarily functions by binding to the GLP-1 receptors in the pancreas, enhancing insulin secretion. The drug's structure extends its activity, making it suitable for once-weekly dosing.
Slowed Gastric Emptying: This action prolongs satiety and reduces meal-related hyperglycemia.
Reduced Appetite: It influences appetite centers in the brain, reducing caloric intake.
Spanning the pharmacokinetic profile, semaglutide has a high binding affinity to albumin, prolonging its half-life and ensuring sustained efficacy with weekly administration.
The clinical outcomes span multiple areas, including:
Blood Sugar Control: Reduced A1c levels and fasting blood glucose.
Weight Loss: Significant weight reduction aiding in overall health improvement.
Cardiovascular Health: Lower rates of major adverse cardiovascular
